Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0003
0.00 (0.00%)
Mar 21, 2024, 12:06 PM EDT - Market closed
Total Valuation
Q BioMed has a market cap or net worth of $43,528.
Market Cap | 43,528 |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Q BioMed has 145.10 million shares outstanding.
Shares Outstanding | 145.10M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.99% |
Owned by Institutions (%) | n/a |
Float | 140.88M |
Valuation Ratios
The trailing PE ratio is 0.01 and the forward PE ratio is 111.11.
PE Ratio | 0.01 |
Forward PE | 111.11 |
PS Ratio | 2.90 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | 0.02 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 5,744.22 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $5,012 |
Profits Per Employee | $492,020 |
Employee Count | 3 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Q BioMed has paid $107,723 in taxes.
Income Tax | 107,723 |
Effective Tax Rate | 6.80% |
Stock Price Statistics
The stock price has decreased by -97.97% in the last 52 weeks. The beta is 79.93, so Q BioMed's price volatility has been higher than the market average.
Beta (1Y) | 79.93 |
52-Week Price Change | -97.97% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.00 |
Relative Strength Index (RSI) | 55.79 |
Average Volume (30 Days) | 60,601 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Q BioMed had revenue of $15,035 and earned $1.48 million in profits. Earnings per share was $0.04.
Revenue | 15,035 |
Gross Profit | -67,667 |
Operating Income | 2.14M |
Pretax Income | 1.58M |
Net Income | 1.48M |
EBITDA | 2.16M |
EBIT | 2.14M |
Earnings Per Share (EPS) | $0.04 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity / Book Value | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | 2.53M |
Capital Expenditures | n/a |
Free Cash Flow | 2.53M |
FCF Per Share | $0.02 |
Margins
Gross margin is -450.06%, with operating and profit margins of 14,212.50% and 9,817.49%.
Gross Margin | -450.06% |
Operating Margin | 14,212.50% |
Pretax Margin | 10,512.07% |
Profit Margin | 9,817.49% |
EBITDA Margin | 14,378.78% |
EBIT Margin | 14,212.50% |
FCF Margin | 16,823.60% |
Dividends & Yields
Q BioMed does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 3,391.06% |
FCF Yield | 5,811.04% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 7, 2015. It was a forward split with a ratio of 2.5:1.
Last Split Date | Aug 7, 2015 |
Split Type | Forward |
Split Ratio | 2.5:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |